01 — At a Glance
The Company Building India’s Sewers While Shareholders Pay For It
- 52-Week High / Low₹706 / ₹374
- Q3 FY26 Revenue (Cons.)₹489 Cr
- Q3 FY26 PAT (Cons.)₹78 Cr
- Q3 EPS₹11.35
- Annualised EPS (Q3×4)₹45.4
- Book Value₹297
- Price to Book1.59x
- Debt / Equity0.30x
- Order Book₹9,000 Cr
- Rating (Infomerics)IVR BBB/A3+
The Funny Part: Ramky is building everything — water treatment plants, pharma parks, sewage systems, industrial zones, roads. Meanwhile, the stock has lost 21.4% in the last 6 months. You’d think a company that’s literally building India’s infrastructure would have a slightly better stock chart. You’d be adorably wrong. Order book at ₹9,000 crore. Debt under ₹600 crore. Promoters sitting pretty with 69.8%. And yet, here we are, down 4.3% over a full year. The market is having a laugh.
02 — Introduction
Welcome to Infrastructure: Where Every Win Feels Like A Loss
Ramky Infrastructure Limited is what happens when a Hyderabad-based family decides to build literally everything India needs. Water treatment plants? Check. Sewage systems? Double-check. Industrial parks? Pharma zones? Roads? Trash-to-energy facilities? Sir, we’re gonna need a bigger punch card.
Founded in 1994 as the flagship of the Ramky Group, RIL has grown into a serious infrastructure play with a presence in 23 states, projects across six major sectors, and what management calls “distinct competitive advantage” (which is corporate speak for “we actually finish projects on time, unlike some contractors we all know”).
The numbers, on paper, look respectable. ₹489 crore quarterly revenue. ₹78 crore profit. An order book worth ₹9,000 crores — that’s about 4.9x annual sales, or nearly 3 years of work if nothing else gets signed. A capital structure that went from absolute leverage disaster (₹2,120 crore debt in FY22) to manageable (₹613 crore in Sep 2025). A credit rating upgrade just last month to IVR BBB with stable outlook.
And yet, the stock has decided to politely excuse itself from the party.
In Q3 FY26, consolidated revenue hit ₹489 crore with PAT of ₹78 crore. That’s an 6.5% quarter-on-quarter bump in sales, and a heroic 39.3% jump in profit. Order book sits at ₹9,000 crore, with around 50% of it in operation & maintenance contracts (low-burn, high-visibility cash). The company is bleeding debt and mining for margin. So logically, the stock should be treating itself to a nice little rally. Instead, it’s down. This is not financial advice, but it is comedy.
From the concall (Feb 2026): Management acknowledged “operational execution progressing well” and highlighted recent ₹3,000 crore pharma park concession win (95-year term, 1,000 hectares). Order book to revenue visibility at 1.96x–3.72x, depending on execution pace. Translation: they’re building aggressively, but recognition lags physical completion by 18–24 months.
03 — Business Model: The Three Boring Buckets
EPC + Developer + O&M: The Trifecta Nobody Talks About At Dinner Parties
Ramky’s business is split into three tired-old-infrastructure-executive segments:
1. Construction Business (EPC) – 72% of FY24 revenue: The company wins contracts through tender, designs + engineers infrastructure, and builds it. Water & wastewater is the crown jewel (~16% of order book as of Mar 2024, but growing). Industrial construction (factories, plants, SEZs) accounts for a fat 52% of the order book. Roads and bridges make up ~2%. Building construction (the residential-commercial variety) another 26%. Model is straightforward: you bid aggressively, get the job, execute conservatively, extract margin. Margin compression happens when you’re hungry for volume.
2. Developer Business (PPP) – 28% of FY24 revenue: RIL undertakes large development projects with government on a Public-Private Partnership basis. Think Industrial Parks (JNPC Vizag, 3,600 acres), pharma zones, integrated townships. These are awarded after tendering and typically involve 20–30 year concession agreements. Operating model: invest capex upfront, recover through user fees over time. Case study: Jawaharlal Nehru Pharmacity at Vizag (450 acres developed, another 2,400 acres in pipeline). Revenue recognition is lumpy, margins are front-loaded in early years when land is being packaged.
3. O&M Contracts – The Gift That Keeps Giving: Operation & Maintenance. Low capex. High visibility. The kind of revenue your CFO wants to hug. About 50% of Ramky’s order book is now O&M contracts, meaning ₹4,500 crore of very predictable, sticky revenue. Water treatment plants, STPs, waste management facilities — once built, they need 15–20 years of annual maintenance and monitoring. Gross margins are mid-20s%, nothing sexy, but revenue is boring-reliable, which is the opposite of what contractors usually deal with.
Industrial52%Order Mix
Buildings26%Order Mix
Water & WWW16%Order Mix
From concalls & filings: Management targets “water & wastewater & urban sanitation” as growth lever. Company completed 185 water projects and 50 industrial projects. Visibility is multi-year. Execution discipline has improved (PDC moderation). New pharma park at Dighi port in Maharashtra (₹3,000 crore project, 95-year concession, signed March 2026) will add ₹1,100 crore EPC and ₹2,700 crore O&M revenue over its life.
💬 If Ramky has 4.9 years of order book visibility, why is the stock down? Is it: (A) Market doesn’t trust timely execution, (B) Earnings recognition lag is killing narrative, or (C) Infrastructure stocks are just perpetually sad? Drop your opinion.
04 — Financials Overview
Q3 FY26: The Quarterly Numbers Everyone Keeps Misinterpreting
Result type: Quarterly Results (Consolidated) | Q3 FY26 EPS: ₹11.35 | Annualised EPS (Q3×4): ₹45.4 | FY25 Full-year EPS: ₹28.54
| Metric (₹ Cr) |
Q3 FY26
Dec 2025 |
Q3 FY25
Dec 2024 |
Q2 FY26
Sep 2025 |
YoY % |
QoQ % |
| Revenue | 489 | 459 | 471 | +6.5% | +3.8% |
| EBITDA | 138 | 129 | 140 | +7.0% | -1.4% |
| EBITDA Margin % | 28.2% | 28.1% | 29.7% | +10 bps | -150 bps |
| PAT | 78 | 60 | 76 | +30.0% | +2.6% |
| EPS (₹) | 11.35 | 8.15 | 10.87 | +39.3% | +4.4% |
Decoding This Quarter: Q3 FY26 is a grower. Revenue +6.5% YoY, PAT +30% YoY. Margins are stable (28.2% EBITDA), though down from Q2’s 29.7% due to execution of lower-margin contracts that were inevitable given the order book. Annualised EPS of ₹45.4 (off Q3 earnings) versus FY25 full-year EPS of ₹28.54 suggests significant growth ahead if quarterly performance sustains. However, the devil is in timing: construction revenue is lumpy, project-by-project. A ₹300+ crore project might have ₹80 cr in one quarter and ₹20 cr in the next, depending on physical milestones achieved. The stock market doesn’t like lumpiness. It prefers predictability. Hence, the discount.
💬 If Q3 showed 39% YoY profit growth, why is the stock still in pain? Is the problem earnings or perception?
05 — Valuation Discussion: Fair Value Range
What’s This Sewer-Building Company Actually Worth?
